Mount Sinai head and neck surgical oncologists are at the forefront of treating head and neck cancers using minimally invasive, transoral robotic surgery. As one of the first adopters of this technology, we also have a wealth of experience in deploying it effectively. Where surgery to access the back of the throat would have previously required splitting the jaw in half and a two week stay in the hospital, many of these tumors are resected robotically through the mouth and with a short stay in the hospital. The surgical robot can be used for tonsil and base of tongue cancers, many of which are HPV+. The robot can also be used for tumors of the larynx and nasopharynx, albeit less commonly so.
Eric M. Genden, MD, MHCA, FACS Dr. Isidore Friesner Professor and Chair of Otolaryngology – Head and Neck Surgery Senior Associate Dean for Clinical Affairs Professor of Neurosurgery and Immunology Icahn School of Medicine at Mount Sinai Director, Head and Neck Institute-Center of Excellence for Head and Neck Cancer Mount Sinai Health System
Michael Berger, MD Assistant Professor, Department of Otolaryngology-Head and Neck Surgery Division of Otology-Neurotology, Lateral Skull Base Surgery Mount Sinai Health System
Raymond L. Chai, MD Associate Professor, Otolaryngology – Head and Neck Surgery Mount Sinai Health System
Marita S. Teng, MD Professor, Otolaryngology – Head and Neck Surgery Mount Sinai Health System
Mark Urken, MD Chief, Division of Head and Neck Surgical Oncology, Co-Director, Institute for Head and Neck and Thyroid Cancer, Department of Otolaryngology, Mount Sinai Union Square Mount Sinai Health System
Zachary G. Schwam, MD Assistant Professor, Department of Otolaryngology-Head and Neck Surgery Division of Otology-Neurotology, Lateral Skull Base Surgery Mount Sinai Health System